NCT00520572 A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT00519077 Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00517387 The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression Status COMPLETED Phase PHASE3
NCT00517283 A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT00516802 A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine Status COMPLETED Phase PHASE1
NCT00516724 Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel Status COMPLETED Phase PHASE1
NCT00516438 Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan Status COMPLETED Phase PHASE1
NCT00516373 A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP) Status COMPLETED Phase PHASE1
NCT00516074 A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00516048 An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00515866 Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00509028 Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma Status COMPLETED Phase PHASE3
NCT00505388 A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice Status COMPLETED Phase N/A
NCT00504062 Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma Status COMPLETED Phase PHASE3
NCT00503477 A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan Status COMPLETED Phase PHASE1